332 related articles for article (PubMed ID: 11937780)
21. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
23. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
24. Role of prostanoids in the contraction induced by a tachykinin NK2 receptor agonist in the hamster urinary bladder.
Tramontana M; Catalioto RM; Lecci A; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):452-9. PubMed ID: 10763862
[TBL] [Abstract][Full Text] [Related]
25. Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle.
Sellers DJ; Chapple CR; W Hay DP; Chess-Williams R
Eur Urol; 2006 Mar; 49(3):510-8. PubMed ID: 16420969
[TBL] [Abstract][Full Text] [Related]
26. In vivo and in vitro activity of SR 48,968, a non-peptide tachykinin NK-2 receptor antagonist.
Giuliani S; Patacchini R; Giachetti A; Maggi CA
Regul Pept; 1993 Jul; 46(1-2):314-6. PubMed ID: 7692525
[No Abstract] [Full Text] [Related]
27. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
[TBL] [Abstract][Full Text] [Related]
28. SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat.
Couture R; Toma N; Barbot L
Life Sci; 2000; 66(1):51-65. PubMed ID: 10658924
[TBL] [Abstract][Full Text] [Related]
29. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
30. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
[TBL] [Abstract][Full Text] [Related]
31. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
Gether U; Emonds-Alt X; Brelière JC; Fujii T; Hagiwara D; Pradier L; Garret C; Johansen TE; Schwartz TW
Mol Pharmacol; 1994 Mar; 45(3):500-8. PubMed ID: 8145735
[TBL] [Abstract][Full Text] [Related]
33. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
[TBL] [Abstract][Full Text] [Related]
34. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
35. Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists.
Nicolau M; Sirois MG; Bui M; Plante GE; Sirois P; Regoli D
Can J Physiol Pharmacol; 1993; 71(3-4):217-21. PubMed ID: 7691388
[TBL] [Abstract][Full Text] [Related]
36. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
38. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat.
Gaudreau GA; Plourde V
Neurosci Lett; 2003 Nov; 351(2):59-62. PubMed ID: 14583381
[TBL] [Abstract][Full Text] [Related]
39. New spiropiperidines as potent and selective non-peptide tachykinin NK2 receptor antagonists.
Smith PW; Cooper AW; Bell R; Beresford IJ; Gore PM; McElroy AB; Pritchard JM; Saez V; Taylor NR; Sheldrick RL
J Med Chem; 1995 Sep; 38(19):3772-9. PubMed ID: 7562907
[TBL] [Abstract][Full Text] [Related]
40. Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder.
Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
Peptides; 1995; 16(4):587-94. PubMed ID: 7479288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
